Toward a Cure for Ebola and Rabies

A new antiviral could tackle two of the world's most feared viral villains.

By Gemma TarlachJan 20, 2014 9:00 PM
Illustration of the ebola virus. | Gl0ck/Shutterstock


Sign up for our email newsletter for the latest science news

Two of the world’s most feared viral villains may have met their match.

Rabies, with a nearly 100 percent mortality rate, and the gruesome hemorrhagic virus Ebola belong to a particularly nasty family — and neither disease has a cure.

In March, John Connor, a virologist at the Boston University School of Medicine, and his team identified a synthetic compound that appears to shut down replication in Ebola and other members of the nonsegmented, negative strand (NNS) RNA virus family. Based on a plant-based class of molecules known as indoline alkaloids, the compound inhibits an enzyme called polymerase, which enables a virus to make thousands of copies of itself and cause disease, explains Claire Marie Filone, the study’s lead author.

Unlike the existing rabies vaccine, which is administered shortly after a bite by a rabid animal and provokes an immune response in the host, potential antiviral treatments developed from the new compound would target NNS RNA viruses directly.

“Our hope is for a cure. This is a step on that path,” says Connor. “At the very least, now we’ve got new tools.”

[This article originally appeared in print as "Ebola and Rabies: Toward a Cure."]

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!


Already a subscriber?

Register or Log In

More From Discover
Recommendations From Our Store
Shop Now
Stay Curious
Our List

Sign up for our weekly science updates.

To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2023 Kalmbach Media Co.